Kane Biotech Inc.
Symbol:
TSXV: KNE
OTCQB: KNBIF
Market Cap:
Private
Sector:
Biotechnology
Summary:
- Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (80 patents and patents pending, trade secrets and trademarks) and products developed by the Company’s own biofilm research expertise and acquired from leading research institutions. StrixNB™, DispersinB®, Aledex™, bluestem™, bluestem®, silkstem™, goldstem™, coactiv+™, coactive+®, DermaKB™, DermaKB Biofilm™ and revyve™ are trademarks of Kane Biotech Inc.
- The Company is listed on the TSX Venture Exchange under the symbol “KNE” and on the OTCQB Venture Market under the symbol “KNBIF”.
Management:
,